Bayer(US:BAYRY) Zhong Guo Jing Ying Bao·2025-11-06 23:40Core Insights - Bayer has participated in the China International Import Expo (CIIE) for eight consecutive years, leveraging the event's spillover effects to accelerate innovation and deepen cooperation [2][3] - The company has witnessed significant achievements, including over 50 product debuts and nearly 40 important contracts signed with various partners in the past seven years [3][6] Group 1: Investment and Market Environment - Bayer views China as one of the most vibrant and influential markets globally, expressing confidence in its investment and development in the region [2][3] - The continuous improvement of the business environment and intellectual property protection in China is seen as a positive factor for Bayer's strategic layout [3][4][5] Group 2: Product and Innovation Development - In the health consumer goods sector, Bayer has launched over 10 new products that have gained popularity among consumers, focusing on digestive health, skin health, and nutritional supplements [6] - Bayer's Crop Science division emphasizes innovation to help farmers increase yield and income, with recent upgrades to its manufacturing center to meet market demands [6][7] Group 3: Future Plans and Collaborations - Bayer is set to open the "Bayer Health Consumer Products China Innovation Cooperation Center" in October 2024, aimed at fostering integrated innovation through collaboration [7] - The company has established a global sustainable agriculture demonstration project, with new regenerative agriculture demonstration farms launched in China, combining local practices with global expertise [7][8] Group 4: CIIE Participation Highlights - At the eighth CIIE, Bayer's exhibition area covered 800 square meters, showcasing 26 highlight products, including 5 global debuts and 8 China debuts [8] - Bayer aims to continue its commitment to open cooperation, focusing on sustainable high-quality development in healthcare and agricultural technology [8]